Acute myeloid leukemia is a poor prognostic blood cancer with dismal survival rates. Major challenges in improving AML survivorship include its heterogeneity and ability to evade immunosurveillance. To facilitate subtyping and therapeutic decision-making, AML ... ...

请注册登录后继续浏览